The once thriving B-ll biotech investment, suddenly no one would touch it overnight.
B-ll is a biotechnology concept related to stem cells, which can treat neurological diseases.
To be precise, B-ll can accurately induce stem cells to differentiate into various types of neurons, and although in vitro, it can replicate the complex neural conditions of the human body at almost a one-to-one ratio, almost like a miracle technique.
It has an extremely high accuracy rate for clinical drug trials, allowing pharmaceutical companies specializing in neurological diseases to observe the effects of drugs on the nervous system, thus developing the most suitable new drugs for these conditions.
Previously, a biotech company in Silicon Valley received hefty investments due to this exclusive patent.
